Antibody dependent enhancement infection of enterovirus 71 in vitro and in vivo.
about
Development of Novel Vaccines against Enterovirus-71Recent Progress towards Novel EV71 Anti-Therapeutics and VaccinesProduction of EV71 vaccine candidatesIs a multivalent hand, foot, and mouth disease vaccine feasible?Therapeutic and prevention strategies against human enterovirus 71 infectionAnimal models of enterovirus 71 infection: applications and limitations.Recombinant tandem multi-linear neutralizing epitopes of human enterovirus 71 elicited protective immunity in miceGlobal transcriptomic analysis of human neuroblastoma cells in response to enterovirus type 71 infectionNovel recombinant chimeric virus-like particle is immunogenic and protective against both enterovirus 71 and coxsackievirus A16 in mice.Parallel mRNA and microRNA profiling of HEV71-infected human neuroblastoma cells reveal the up-regulation of miR-1246 in association with DLG3 repressionImmunological evaluation and comparison of different EV71 vaccine candidates.Human IgG subclasses against enterovirus Type 71: neutralization versus antibody dependent enhancement of infection.Coxsackievirus A16 induced neurological disorders in young gerbils which could serve as a new animal model for vaccine evaluationSystematic Identification and Bioinformatic Analysis of MicroRNAs in Response to Infections of Coxsackievirus A16 and Enterovirus 71.Scavenger receptor b2 as a receptor for hand, foot, and mouth disease and severe neurological diseases.Update of enterovirus 71 infection: epidemiology, pathogenesis and vaccine.Update on the development of enterovirus 71 vaccines.Determination of antibody concentration as the main parameter in a dengue virus antibody-dependent enhancement assay using FcγR-expressing BHK cells.Adoptive transfer of macrophages from adult mice reduces mortality in mice infected with human enterovirus 71.EV71 infection correlates with viral IgG preexisting at pharyngo-laryngeal mucosa in children.EV71 vaccines: a first step towards multivalent hand, foot and mouth disease vaccines.Structure, Immunogenicity, and Protective Mechanism of an Engineered Enterovirus 71-Like Particle Vaccine Mimicking 80S Empty Capsid.Subneutralizing antibodies to enterovirus 71 induce antibody-dependent enhancement of infection in newborn mice.Epidemiology of Recurrent Hand, Foot and Mouth Disease, China, 2008-2015.Epidemic dynamics, interactions and predictability of enteroviruses associated with hand, foot and mouth disease in Japan
P2860
Q26771247-89FAADEC-C003-4D04-A514-32F005B057AAQ26775734-B5C7596D-96D0-44FD-86CC-66A6AC7D8D0EQ26866091-0DF18E1B-CF11-40DE-BD29-630611B8D982Q27010349-6E4BA12E-9562-47EE-B5C8-F1962C03BA31Q28080796-0C99FF00-79DB-4AA9-ACB4-F80FD7C3CE6EQ33579809-E769C74C-AEF4-457E-A38F-FC9F15507B31Q33646488-C43DF577-1364-473A-9111-9A09FD3CE899Q34825259-F47EE69A-39A7-405C-B398-1CB2AE9BBFE5Q34981056-E242BDB3-50DC-426F-8606-CE6C98A4F082Q35150392-987DCB0E-424B-4CA1-930C-8D7AA26FC54CQ36248450-80771B07-510F-4C1E-93FD-EF88E5216025Q36859366-94384CA6-BAC9-4BCD-B871-93FEC6BFBE27Q37281676-CFE93F45-94AB-45E6-AE01-3306F5921245Q37397124-660C119C-B1E3-42EE-9689-2DCDF13FD5D2Q37987923-6F661FAC-AEC5-4C2C-8CCA-D89D42EB0D10Q38192021-65984BDB-428E-4603-84C0-C2AACEDE619FQ38225695-D526AB1F-819C-41A2-AC1D-D88E278EEE0CQ39117650-82420E45-5494-4D94-A100-8CF624D7A1DFQ39240063-F4D9E26E-3CFB-4254-BB20-B28D284B78E7Q41153130-DD0CACA6-1875-4475-A86E-2D96D8936D31Q41583962-721303FE-8487-47E0-843F-2856E72B7F9FQ47600312-558C1EF5-437B-44E9-96F7-87C988E583C9Q48163643-AAA31A79-D6C7-4C33-A367-88F93F480C77Q49820089-1AF3ACEE-BE56-4143-86AC-27EBBACFB8C7Q58744923-43771236-4139-4D26-981D-B45586F690F5
P2860
Antibody dependent enhancement infection of enterovirus 71 in vitro and in vivo.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Antibody dependent enhancement infection of enterovirus 71 in vitro and in vivo.
@ast
Antibody dependent enhancement infection of enterovirus 71 in vitro and in vivo.
@en
Antibody dependent enhancement infection of enterovirus 71 in vitro and in vivo.
@nl
type
label
Antibody dependent enhancement infection of enterovirus 71 in vitro and in vivo.
@ast
Antibody dependent enhancement infection of enterovirus 71 in vitro and in vivo.
@en
Antibody dependent enhancement infection of enterovirus 71 in vitro and in vivo.
@nl
prefLabel
Antibody dependent enhancement infection of enterovirus 71 in vitro and in vivo.
@ast
Antibody dependent enhancement infection of enterovirus 71 in vitro and in vivo.
@en
Antibody dependent enhancement infection of enterovirus 71 in vitro and in vivo.
@nl
P2093
P2860
P356
P1433
P1476
Antibody dependent enhancement infection of enterovirus 71 in vitro and in vivo.
@en
P2093
Jian-Feng Han
Rui-Yuan Cao
P2860
P356
10.1186/1743-422X-8-106
P577
2011-03-08T00:00:00Z